Home / Knowledge Centre /
Article

Technology-driven isotopic labelling in API development

Isotopic labelling of APIs is becoming more challenging, particularly for complex targeted therapies.

The application of biocatalytic tools can introduce complex functionality in a single step and reduce the cost of developing labelled biomolecules and chiral compounds.

View Resource

Please complete this form to view the Article

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies